Compare the Impact of Xuezhikang and Atorvastatin on Glucose Metabolism in Dyslipidemia Patients With Prediabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

392

Participants

Timeline

Start Date

August 2, 2022

Primary Completion Date

April 2, 2024

Study Completion Date

April 2, 2024

Conditions
Metabolism Disorder, LipidMetabolism Disorder, Glucose
Interventions
DRUG

Xuezhikang Capsule

Xuezhikang Capsule, 1200mg / day, twice a day, 2 capsules each time, after meals in the morning and evening.

DRUG

Atorvastatin Calcium Tablets

Atorvastatin Calcium Tablets, 20mg/day, once a day, one tablet each time, before bedtime;

Trial Locations (1)

Unknown

Peking University People's Hospital, Beijing

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Heart Health Research Center

OTHER